Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Merck’s vericiguat gains FDA approval for treating high-risk chronic heart failure patients

Sold as Verquvo, the medication can help patients reduce their risk of cardiovascular death or hospitalization for heart failure.

Thumbnail

Diabetes, insulin resistance strongly associated with premature coronary heart disease among women

The study’s authors explored data from more than 28,000 women, focusing on the impact of dozens of biomarkers. 

Thumbnail

Nighttime cardiac arrest, a ‘perplexing and devastating phenomenon,’ more common among women

Physicians may want to think twice before prescribing certain medications, including drugs for pain or depression, to some female patients, the authors observed. 

Thumbnail

CMS expands Medicare coverage for TMVR, now known as TEER, to include patients with functional MR

Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 

24% of heart failure patients hospitalized with COVID-19 die

The authors examined data from more than 1.2 million patients, tracking individuals who had previously been hospitalized for heart failure and then returned later due to COVID-19. 

Thumbnail

TAVR in the time of COVID-19: Providers quickly adapted, delivering ‘excellent’ outcomes

Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  

Thumbnail

What new research tells us about stroke mortality among men and women

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 

Thumbnail

No reason to quit: TAVR patients can continue anticoagulation therapy throughout procedure

Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.